# Developmental Funds

> **NIH NIH P30** · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2022 · $776,186

## Abstract

Abstract: Developmental Funds
Cancer Center Support Grant (CCSG) Developmental Funds provide discretionary support to help Hillman
Cancer Center (HCC) achieve the goals established during strategic planning and evaluation activities. During
the current period, HCC used these funds to make key faculty recruitments, launch innovative ideas, adopt
technical advances within our Shared Resources, and support Staff Investigators. The HCC Senior Leadership
Team (SLT) determines the priorities for the allocation of Developmental Funds and supplemental institutional
support, with input from the Research Executive Advisory Committee (REAC) and the External Advisory Board
(EAB), to ensure alignment with CCSG guidelines and the HCC strategic plan. CCSG Developmental Funds
supported 10 faculty recruits; 21 pilot projects that allowed members to pursue innovative, high-risk ideas or
work in high priority research areas; added new technologies and capabilities for re-configuration of HCC
Shared Resources; and supported 3 Staff Investigators who significantly contributed to research, clinical, and
educational efforts at HCC.
Developmental Funds leveraged institutional support and generated a significant return on investment, with
$948K CCSG funds allocated to 10 new faculty recruits over this grant period, generating a total of $19.5M in
external awards and clinical trials; a 20.5-fold return on investment (ROI). The $19.5M includes $7.5M million
in NCI funding, an ROI of 7.9-fold on the invested CCSG funds. Given the successful use of Developmental
Funds in the current project period, we request $534,736 per year to be used in the following categories: 1)
Recruit faculty in areas of strategic need to strengthen basic, clinical, translational, and population sciences
research; 2) Support pilot projects that allow HCC scientists to pursue innovative, high-risk ideas or work in
high priority research areas, including team science projects; 3) Develop new Shared Resources or
capabilities, such as the Microbiome Facility and Population Survey Facility; and, 4) Support CCSG Research,
Clinical, and Early-Stage Clinical Staff Investigators to drive collaboration, science, and clinical activity across
the HCC.

## Key facts

- **NIH application ID:** 10474540
- **Project number:** 5P30CA047904-34
- **Recipient organization:** UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- **Principal Investigator:** Robert L. Ferris
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $776,186
- **Award type:** 5
- **Project period:** 1997-09-10 → 2025-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10474540

## Citation

> US National Institutes of Health, RePORTER application 10474540, Developmental Funds (5P30CA047904-34). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10474540. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*